Skip to main content
OpenTrials
Completed

NCT Number: NCT06667310

Effects of Neutrophil/Lymphocyte, Platelet/Lymphocyte, CRP/Albumin and Lactate on Mortality in Trauma Patients Admitted to Intensive Care

Intensive care units are medical units where patients are closely monitored 24 hours a day due to critical health problems that threaten their lives and where rapid interventions are made when necessary. The clinical conditions of patients in these units can change rapidly. There are many studies in the literature indicating that inflammation indicators such as Neutrophil/Lymphocyte, Platelet/Lymphocyte and C-Reactive Protein/Albumin ratios and blood gas values such as Lactate and Base Deficit are simple, cheap and rapid biomarkers that can provide an early idea about the clinical course of patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Intensive Care

Age range

1 year–95 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Veli Fahri Pehlivan

Karaköprü, Şanliurfa, 63100, Turkey (Türkiye)

About this study

Intensive care units are medical units where patients are closely monitored 24 hours a day due to critical health problems that threaten their lives and where rapid interventions are made when necessary. The clinical conditions of patients in these units can change rapidly. There are many studies in the literature indicating that inflammation indicators such as Neutrophil/Lymphocyte, Platelet/Lymphocyte and C-Reactive Protein/Albumin ratios and blood gas values such as Lactate and Base Deficit are simple, cheap and rapid biomarkers that can provide an early idea about the clinical course of patients. The researchers aimed to evaluate the relationship between Neutrophil/Lymphocyte, Platelet/Lymphocyte and C-Reactive Protein/Albumin ratios and biomarkers such as Lactate and Base Deficit with the clinical course and survival of trauma patients admitted to the ICU and to see the compatibility of our data with the existing literature.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 1. All trauma patients admitted to our general intensive care unit

Exclusion criteria

  • 1. Patients whose follow-up and treatment started and completed in the services.
  • Patients whose data is missing or whose data cannot be accessed.

Treatment and study plan

Primary outcomes

  1. Primary outcome

    Time frame: one day

    • LACTATE LEVELS RATİO MEASUREMENT

Secondary outcomes

  1. seconary outcome

    Time frame: one day

    The effect of these measurements on mortality

Sponsors and collaborators

Lead sponsor

Harran University

Other

Registry information

Official study title

Evaluatıon Of The Effect Of Neutrophıl/Lymphocyte, Platelet/Lymphocyte, Crp/Albumın, Base Defıcıt And Lactate Levels On Mortalıty Durıng The Admıssıon Of Trauma Patıents To Intensıve Care

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Oct 31, 2024
Registry last updated
May 15, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.